Stemness-Attenuating miR-503-3p as a Paracrine Factor to Regulate Growth of Cancer Stem Cells

Area of Science:

• Molecular Biology
• Cancer Research
• Stem Cell Biology

Background:

• Cancer stem cells (CSCs) drive tumor heterogeneity, metastasis, and recurrence.
• Current therapeutic strategies lack efficacy against CSCs.
• Targeting CSC self-renewal is a critical unmet need in cancer therapy.

Purpose of the Study:

• To investigate the therapeutic potential of miR-503-3p against cancer stem cells.
• To determine if miR-503-3p, derived from adipose stem cell- (ASC-) exosomes, can inhibit CSC proliferation and self-renewal.
• To evaluate the in vivo efficacy of miR-503-3p in reducing tumor growth.

Main Methods:

• Isolation of miR-503-3p from ASC-derived exosomes.
• Assessment of CSC self-renewal using anchorage-dependent (colony formation) and anchorage-independent (tumorsphere formation) assays.
• Quantification of pluripotency gene expression in treated CSCs.
• In vivo evaluation of tumor growth in xenograft models.

Main Results:

• miR-503-3p significantly suppressed CSC proliferation and self-renewal in vitro.
• Treatment with miR-503-3p led to a notable decrease in pluripotency gene expression.
• In vivo xenografts treated with miR-503-3p demonstrated significantly reduced tumor growth.

Conclusions:

• miR-503-3p acts as a potent inhibitor of cancer stem cell stemness.
• ASC-derived exosomal miR-503-3p holds promise as a novel therapeutic agent.
• miR-503-3p may mediate its effects through intercellular communication, attenuating stemness.